These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Author: Bryskier A, Humbert G, Borsa F, Bertrand A, Janbon F, Lafaix C, Beucler A, Veyssier P, Dusehu E, Modai J.
    Journal: Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392.
    Abstract:
    Cefotiam (SCE 963), a new, broad-spectrum, third generation cephalosporin was used in the treatment of 136 patients suffering from respiratory tract infections, urinary tract infections, septicemia, meningitis, biliary tract infections and osteoarthritis infections. Cefotiam was administered in monotherapy to 98 patients at the mean posology of two grams per day (extreme doses: 1 to 6 g). The following clinical effectiveness was noted: 83 successes and 18 failures on 101 available clinical reports. The general, biological tolerance and renal tolerance was good in all patients.
    [Abstract] [Full Text] [Related] [New Search]